Implantable cellular and biotherapeutic agent delivery canister
US11857673B2 · kind B2 · utility
1Cited by
10References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 24, 2022 |
| Grant date | Jan 2, 2024 |
| Priority date | — |
| Expiry date | Oct 24, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2205/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A material includes a metallic, nanoporous structure having a plurality of nanopores having a porosity that allows passage of insulin but not IgG. The metallic nanoporous structure includes titanium, 316L stainless steel and may have a textured nano-sericeous surface. A nanoporous bicontinuous structure can be integrated with nanopores.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.